An open-label study of FPF1011 in patients with cerebrotendinous xanthomatosis (phase 3)
An open-label study of FPF1011 in patients with cerebrotendinous xanthomatosis (phase 3)
Cerebrotendinous xanthomatosis
Intervention name : FPF1011 INN of the intervention : Chenodeoxycholic acid Dosage And administration of the intervention : Dose of chenodeoxycholic acid is 750 mg/day for patients aged 20 or older, and 15 mg/kg/day under ages 20, administered orally in three divided doses a day. Control intervention name : - INN of the control intervention : - Dosage And administration of the control intervention : - Intervention name : FPF1011 INN of the intervention : Chenodeoxycholic acid Dosage And administration ...